Imaging NSCLC treatment response to immunotherapy

• Research type

  Research Study

• Full title

  Imaging NSCLC treatment response to immunotherapy: Relating inflammatory activity on 18FDG PET to tumour specific measures from DW-MRI

• IRAS ID

  180083

• Contact name

  Tiffany Rushen

• Contact email

  tiffany.rushen@rmh.nhs.uk

• Sponsor organisation

  Institute of Cancer Research

• Duration of Study in the UK

  2 years, 0 months, 1 days

• Research summary

  Summary of Research
  Unfortunately due to the poor recruitment of participants to study, we had insufficient data for any conclusions to be drawn

• REC name

  London - Surrey Borders Research Ethics Committee

• REC reference

  16/LO/0063

• Date of REC Opinion

  21 Jan 2016

• REC opinion

  Favourable Opinion